Prelude Capital Management’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-400
Closed -$23K – 2148
2019
Q3
$23K Buy
+400
New +$24.8K ﹤0.01% 1364
2017
Q3
– Sell
-200
Closed -$5K – 1821
2017
Q2
$5K Sell
200
-205
-51% -$5.01K ﹤0.01% 1468
2017
Q1
$8K Buy
+405
New +$7.49K ﹤0.01% 1380
2016
Q3
– Sell
-2,745
Closed -$38K – 1742
2016
Q2
$38K Buy
2,745
+2,343
+583% +$33K 0.01% 1100
2016
Q1
$6K Buy
+402
New +$5.89K ﹤0.01% 1191
2015
Q4
– Sell
-555
Closed -$7K – 1615
2015
Q3
$7K Sell
555
-1,432
-72% -$19K ﹤0.01% 1372
2015
Q2
$28K Sell
1,987
-500
-20% -$7.08K ﹤0.01% 1291
2015
Q1
$36K Sell
2,487
-2,413
-49% -$34.1K 0.01% 1561
2014
Q4
$69K Buy
4,900
+2,200
+81% +$32.3K 0.01% 1148
2014
Q3
$35K Sell
2,700
-4,400
-62% -$60.5K ﹤0.01% 1550
2014
Q2
$99K Buy
+7,100
New +$107K 0.01% 1103

Other funds holding NRC

Prelude Capital Management's NRC Position: Q4 2019 in Review

Prelude Capital Management sold out of NRC Health Common Stock (NRC) in Q4 2019, closing a stake of 400 shares — an estimated $23K sold.

Prelude Capital Management first reported a position in NRC in Q2 2014 and held it in 11 quarters. The position peaked at $99K in Q2 2014. 103 funds tracked by Wall St. Rank hold NRC as of Q4 2019.

  • Prelude Capital Management reported no remaining NRC Health Common Stock position as of Q4 2019 after selling out during the quarter.
  • Prelude Capital Management sold 400 NRC Health Common Stock shares in Q4 2019, an estimated $23K.
  • Prelude Capital Management first reported a position in NRC Health Common Stock in Q2 2014 and held it in 11 quarters.
  • Prelude Capital Management's NRC Health Common Stock position peaked at $99K in Q2 2014.
  • 103 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q4 2019.

Based on Prelude Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.